Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches

Identifieur interne : 001B42 ( Main/Exploration ); précédent : 001B41; suivant : 001B43

Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches

Auteurs : Joerg Wenzel [Allemagne] ; Thomas Tüting [Allemagne]

Source :

RBID : ISTEX:7C30BE74E0BC069FB08C01D346D6EBD6BB54082F

English descriptors

Abstract

Abstract:  Cutaneous lupus erythematosus (CLE) is one of the most common dermatological autoimmune disorders worldwide. Recently, several studies provided evidence for a pathogenic role of type I interferons (IFNs) in this disease. Plasmacytoid dendritic cells are major type I IFN producers in CLE skin lesions. Type I IFNs are able to induce the expression of several proinflammatory chemokines, including CXCL9 and 10, and enhance the cytotoxic capacity of infiltrating cells. Additionally, adhesion molecules and chemokine receptors, such as intercellular adhesion molecule‐1, cutaneous lymphocyte antigen, E‐selectin, CCR4 and CXCR3, are involved in the recruitment of potentially autoreactive lymphocytes into the skin. Here, we review the role of type I IFNs, adhesion molecules and chemokine receptors in CLE and discuss options for novel therapeutic approaches.

Url:
DOI: 10.1111/j.1600-0625.2007.00556.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches</title>
<author>
<name sortKey="Wenzel, Joerg" sort="Wenzel, Joerg" uniqKey="Wenzel J" first="Joerg" last="Wenzel">Joerg Wenzel</name>
</author>
<author>
<name sortKey="Tuting, Thomas" sort="Tuting, Thomas" uniqKey="Tuting T" first="Thomas" last="Tüting">Thomas Tüting</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7C30BE74E0BC069FB08C01D346D6EBD6BB54082F</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1111/j.1600-0625.2007.00556.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-HW41F5D5-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000117</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000117</idno>
<idno type="wicri:Area/Istex/Curation">000117</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A25</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A25</idno>
<idno type="wicri:doubleKey">0906-6705:2007:Wenzel J:identification:of:type</idno>
<idno type="wicri:Area/Main/Merge">001B53</idno>
<idno type="wicri:Area/Main/Curation">001B42</idno>
<idno type="wicri:Area/Main/Exploration">001B42</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches</title>
<author>
<name sortKey="Wenzel, Joerg" sort="Wenzel, Joerg" uniqKey="Wenzel J" first="Joerg" last="Wenzel">Joerg Wenzel</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Bonn, Bonn</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tuting, Thomas" sort="Tuting, Thomas" uniqKey="Tuting T" first="Thomas" last="Tüting">Thomas Tüting</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Bonn, Bonn</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Experimental Dermatology</title>
<title level="j" type="alt">EXPERIMENTAL DERMATOLOGY</title>
<idno type="ISSN">0906-6705</idno>
<idno type="eISSN">1600-0625</idno>
<imprint>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="454">454</biblScope>
<biblScope unit="page" to="463">463</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2007-05">2007-05</date>
</imprint>
<idno type="ISSN">0906-6705</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0906-6705</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad dermatol</term>
<term>Acta derm venereol</term>
<term>Adhesion</term>
<term>Adhesion molecules</term>
<term>Antinuclear antibodies</term>
<term>Antiviral</term>
<term>Apoptosis</term>
<term>Apoptotic</term>
<term>Apoptotic cells</term>
<term>Apoptotic keratinocytes</term>
<term>Arthritis rheum</term>
<term>Authors journal compilation</term>
<term>Autoantibody</term>
<term>Autoimmune</term>
<term>Autoimmune disorders</term>
<term>Blackwell munksgaard</term>
<term>Ccr4</term>
<term>Cdle</term>
<term>Chemokine</term>
<term>Chemokine receptor cxcr3</term>
<term>Chemokine receptors</term>
<term>Chemokines</term>
<term>Chloroquine</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Clinical observations</term>
<term>Cutaneous</term>
<term>Cutaneous lupus erythematosus</term>
<term>Cxcr3</term>
<term>Cytokine</term>
<term>Cytokine secretion</term>
<term>Cytotoxic</term>
<term>Cytotoxic lymphocytes</term>
<term>Dendritic</term>
<term>Dense perivascular</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Disease activity</term>
<term>Eloranta</term>
<term>Epidermal</term>
<term>Erythematosus</term>
<term>Experimental dermatology</term>
<term>Ifns</term>
<term>Immune</term>
<term>Immune complexes</term>
<term>Immunol</term>
<term>Interferon</term>
<term>Large amounts</term>
<term>Lesion</term>
<term>Lesional</term>
<term>Lesional skin</term>
<term>Ligand</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Lupus erythematosus tumidus</term>
<term>Lymphocyte</term>
<term>Lymphocyte apoptosis</term>
<term>Lymphocyte recruitment</term>
<term>Methotrexate</term>
<term>Munksgaard</term>
<term>Natural cells</term>
<term>Ndings</term>
<term>Pathogenic</term>
<term>Pathogenic role</term>
<term>Pathway</term>
<term>Pdcs</term>
<term>Plasmacytoid</term>
<term>Plasmacytoid dendritic cells</term>
<term>Proc natl acad</term>
<term>Recent studies</term>
<term>Receptor</term>
<term>Rheum</term>
<term>Ronnblom</term>
<term>Skin lesions</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Tlr9</term>
<term>Viral</term>
<term>Wenzel</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract:  Cutaneous lupus erythematosus (CLE) is one of the most common dermatological autoimmune disorders worldwide. Recently, several studies provided evidence for a pathogenic role of type I interferons (IFNs) in this disease. Plasmacytoid dendritic cells are major type I IFN producers in CLE skin lesions. Type I IFNs are able to induce the expression of several proinflammatory chemokines, including CXCL9 and 10, and enhance the cytotoxic capacity of infiltrating cells. Additionally, adhesion molecules and chemokine receptors, such as intercellular adhesion molecule‐1, cutaneous lymphocyte antigen, E‐selectin, CCR4 and CXCR3, are involved in the recruitment of potentially autoreactive lymphocytes into the skin. Here, we review the role of type I IFNs, adhesion molecules and chemokine receptors in CLE and discuss options for novel therapeutic approaches.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>District de Cologne</li>
<li>Rhénanie-du-Nord-Westphalie</li>
</region>
<settlement>
<li>Bonn</li>
</settlement>
</list>
<tree>
<country name="Allemagne">
<region name="Rhénanie-du-Nord-Westphalie">
<name sortKey="Wenzel, Joerg" sort="Wenzel, Joerg" uniqKey="Wenzel J" first="Joerg" last="Wenzel">Joerg Wenzel</name>
</region>
<name sortKey="Tuting, Thomas" sort="Tuting, Thomas" uniqKey="Tuting T" first="Thomas" last="Tüting">Thomas Tüting</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B42 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B42 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7C30BE74E0BC069FB08C01D346D6EBD6BB54082F
   |texte=   Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021